Ironwood Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowe…

Drug Manufacturers - Specialty & Generic
US, Boston [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Ironwood Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of IRWD's Analysis
CIK: 1446847 CUSIP: 46333X108 ISIN: US46333X1081 LEI: - UEI: -
Secondary Listings
IRWD has no secondary listings inside our databases.